Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.
FDA expands emergency use of Gilead’s remdesivir in hospitalised COVID-19 patients
- Advertisement -
Most Popular
Morgan Stanley widens gap as banks’ wealth units add US$5 trillion
MORGAN Stanley’s record quarter in wealth management capped a banner period for one of Wall Street’s most-profitable businesses.
